Clinical trial · Observational
A Prospective Patient Reported Outcomes and Wearables Study in Myeloproliferative Neoplasms
A Prospective Digital Monitoring Project Exploring Physical Activity, Patient Reported Outcome Measures and Disease Outcomes in Individuals With Myeloproliferative Neoplasms
NCT06334913CI-TRIAL-00075491not yet recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The investigators will assess the use of a smart phone app to monitor patient reported outcomes and record biometric data in patients with myeloproliferative neoplasms.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Myeloproliferative Neoplasm | Myeloproliferative Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- MPN patients
- description
- U.K. based adult patients with MPN diagnosis.
Primary outcomes (1)
- measure
- Patient reported outcomes - Myeloproliferative Neoplasm-10 Total Symptom Score
- timeFrame
- 5 years
- description
- The primary outcome of this study will be to characterise a baseline of healthcare data, patient reporting of symptom burden (as per MPN 10 symptom assessment form, raneg 0-100, higher scores indicative of greater symptom burden) to understand its relevance for disease-specific clinical outcomes.
Secondary outcomes (4)
- measure
- Healthcare adherence
- timeFrame
- 5 years
- description
- To determine the association between patients' adherence to medication, number of hospital attendances and admissions, and data from the wearables.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Diagnosis of MPN. 2. Resident in the UK 3. Aged 18 years and over. 4. Able to confidently converse in English language. 5. Access to smartphone/ mobile phone. 6. Capable of providing informed consent. 7. Physically able to stand and ambulate independently (for substudy). Exclusion Criteria: * Patients with a known allergic reaction to any materials in the wearable device (substudy). * Patients who for any reason are not able to have a wearable (substudy). For example Withings ScanWatch should not be be used if the patient has an implantable electronic device such as a pacemaker or implantable cardioverter-defibrillator
References
Publications (0)
Data not yet available
No reference posted for this study.